Elevated Low-Density Lipoprotein in Alzheimer's Disease Correlates with Brain Aβ 1–42 Levels
Yu‐Min Kuo(National Yang Ming Chiao Tung University), Alex E. Roher(Barrow Neurological Institute), Heather C. Lampert(Banner Sun Health Research Institute), Denise A. Drumm(Banner Sun Health Research Institute), Charles L. Bisgaier, Arnold D. Essenburg, Mark R. Emmerling
Cited by 312
Related Papers
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
|American Journal Of Pathology|1999|1.5k
Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease.
|Journal of Biological Chemistry|1993|799
beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease.
|Proceedings of the National Academy of Sciences|1993|742
Cerebral Amyloid Angiopathy
|American Journal Of Pathology|1998|682